Market Closed -
Other stock markets
|
After market 06:00:04 pm | |||
418 USD | +0.17% | 422.7 | +1.13% |
Mar. 21 | Vertex Pharmaceuticals Gets FDA Approval for VX-407's Investigational New Drug Application to Treat Kidney Disease | MT |
Mar. 21 | Vertex Gets FDA OK to Study VX-407 in Genetic Kidney Disease | DJ |
Filters
- Stock
- Equities
- Stock Vertex Pharmaceuticals Incorporated - Nasdaq
- News Vertex Pharmaceuticals Incorporated